Evidence map›Paper›PMID 40171356›Full record

ArticleCureus2025

Clozapine-Induced Acute Pericarditis and Cardiac Tamponade: Early Recognition Improves Clinical Outcomes.

Muhammad Waqar Elahi, David Shi, Eric Huang, Bharath Bhushan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammad Waqar ElahiMedicine, West Virginia University School of Medicine, Morgantown, USA.
David ShiInternal Medicine, West Virginia University School of Medicine, Morgantown, USA.
Eric HuangInternal Medicine, West Virginia University School of Medicine, Morgantown, USA.
Bharath BhushanInternal Medicine, West Virginia University School of Medicine, Morgantown, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clozapine is approved for treatment-resistant schizophrenia. Many cardiovascular side effects are associated with clozapine, including QTc prolongation and myocarditis, which is a black box warning. Few cases of pericarditis have been reported in recent literature. We report a case of a 26-year-old male with schizoaffective disorder who presented with sharp chest pain and shortness of breath. The patient was started on clozapine three months prior to his current presentation. The workup revealed a large pericardial effusion with cardiac tamponade physiology and signs consistent with acute pericarditis. He required emergent pericardiocentesis and pericardial drain placement. Symptoms resolved after treatment with ibuprofen and colchicine. This case report highlights the importance of early diagnosis of life-threatening cardiovascular complications associated with clozapine, especially acute pericarditis and cardiac tamponade due to pericardial effusion. We strongly recommend implementing monitoring protocols to prevent this potentially life-threatening adverse effect in patients taking clozapine.

Indexed as

acute pericardial effusionanti-psychotic drugcardiac tamponadeclozapine side effectspericarditistreatment resistant schizophrenia

Identifiers

PMID40171356
PMCPMC11961079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.